Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

AI test aims to predict best cancer drugs from tiny tumor sample

NCT ID NCT05478538

Recruiting now Diagnosis Sponsor: Elephas Source: ClinicalTrials.gov ↗

Summary

This study is testing a new diagnostic tool called the Cybrid platform. It aims to see if analyzing small pieces of a patient's lung tumor in a lab can accurately predict whether that patient will respond to certain immunotherapy drugs. The study will enroll 200 people with advanced non-small cell lung cancer and compare the tool's predictions to how patients actually respond to treatment.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NSCLC (NON-SMALL CELL LUNG CANCER) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Baylor Scott & White Research Institute

    RECRUITING

    Temple, Texas, 76508, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Gabrail Cancer Center

    TERMINATED

    Canton, Ohio, 44718, United States

  • JPS Health Network

    RECRUITING

    Fort Worth, Texas, 76104, United States

    Contact Email: •••••@•••••

    Contact

  • James M Stockman Cancer Institute

    RECRUITING

    Frederick, Maryland, 21702, United States

    Contact

    Contact Email: •••••@•••••

  • New York Cancer & Blood Specialists

    RECRUITING

    Shirley, New York, 11967, United States

    Contact Email: •••••@•••••

    Contact

  • UCLA Medical Center

    RECRUITING

    Los Angeles, California, 90095, United States

    Contact

    Contact Email: •••••@•••••

  • University of North Carolina at Chapel Hill

    TERMINATED

    Chapel Hill, North Carolina, 27599, United States

Conditions

Explore the condition pages connected to this study.

METASTATIC NSCLC - NON-SMALL CELL LUNG CANCER NSCLC (NON-SMALL CELL LUNG CANCER)